1. Food and Drug Administration.Guidance for industry multiple endpoints in clinical trials (draft).https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm536750.pdf. Published January2017.
2. European Medicines Agency.Guideline on multiplicity issues in clinical trials (draft).http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2017/03/WC500224998.pdf. Published April2017.
3. A graphical approach to sequentially rejective multiple test procedures
4. A recycling framework for the construction of Bonferroni-based multiple tests
5. Multiple comparisons in drug clinical trials and preclinical assays: a‐priori ordered hypotheses;Maurer W;Biomed Chem Pharm Ind,1995